Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 108

Results For "AI"

7410 News Found

Biogen to invest $2 billion to expand manufacturing capability in North Carolina
News | July 21, 2025

Biogen to invest $2 billion to expand manufacturing capability in North Carolina

Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date


Bristol Myers Squibb announces topline Results from Phase 3 Independence trial for Reblozyl
Diagnostic Center | July 19, 2025

Bristol Myers Squibb announces topline Results from Phase 3 Independence trial for Reblozyl

Reblozyl is a standard of care for the first-line treatment of anemia without previous erythropoiesis stimulating agent use


Kenvue collaborates with API to launch India’s first cough clinics
Healthcare | July 18, 2025

Kenvue collaborates with API to launch India’s first cough clinics

Aims to support healthcare practitioners with evidence-based cough categorization tools that enable choosing the right molecules for effective & targeted relief from cough


Vimta Labs Q1 FY26 PAT climbs to Rs. 18.89 Cr
News | July 18, 2025

Vimta Labs Q1 FY26 PAT climbs to Rs. 18.89 Cr

Vimta Labs has reported total income of Rs. 99.31 crores during the period ended June 30, 2025


Brenntag Specialties Pharma offering phosphate-based excipients by Budenheim
Supply Chain | July 18, 2025

Brenntag Specialties Pharma offering phosphate-based excipients by Budenheim

Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes


Shilpa Medicare receives EIR from USFDA for Unit VI, Bengaluru
Drug Approval | July 17, 2025

Shilpa Medicare receives EIR from USFDA for Unit VI, Bengaluru

This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms


Lupin launches Loteprednol Etabonate ophthalmic suspension 0.5% in US
News | July 17, 2025

Lupin launches Loteprednol Etabonate ophthalmic suspension 0.5% in US

Loteprednol Etabonate Ophthalmic Suspension, 0.5% is indicated for the treatment of steroidresponsive inflammatory conditions of the palpebral and bulbar conjunctiva


Plant-based chemistry essential for home and personal care products:  Vishal Sharma, Executive Director & Chief Executive Officer (Chemicals), Godrej Industries
Opinion | July 17, 2025

Plant-based chemistry essential for home and personal care products: Vishal Sharma, Executive Director & Chief Executive Officer (Chemicals), Godrej Industries

Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products